China Shineway Pharmaceutical Group Limited

CSWYF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$1,146$137$108$86
Dep. & Amort.$69$9$9$10
Deferred Tax$0$0$0-$43
Stock-Based Comp.$0$0$0$0
Change in WC$222-$24$43$7
Other Non-Cash-$473$19$19$61
Operating Cash Flow$963$141$179$120
Investing Activities
PP&E Inv.-$140-$20-$19-$14
Net Acquisitions$1$0$1$14
Inv. Purchases-$845-$74-$45-$57
Inv. Sales/Matur.$528$75$46$59
Other Inv. Act.$184$3$1$2
Investing Cash Flow-$272-$16-$17$3
Financing Activities
Debt Repay.$30$42-$1-$369
Stock Issued$0$0$0$4
Stock Repurch.$0$0$0$0
Dividends Paid-$408-$45-$35-$71
Other Fin. Act.-$15-$24-$1$688
Financing Cash Flow-$392-$27-$37-$128
Forex Effect-$47$6$6-$7
Net Chg. in Cash$251$105$66$11
Supplemental Information
Beg. Cash$5,889$729$660$649
End Cash$6,140$830$725$660
Free Cash Flow$823$120$159$106